Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Nuvation Bio Inc.

NYSE: NUVB · Life Sciences · 3 alerts · CIK 1811063

Share price
$3.84Close, Nov 16
Market cap
$1.36B
Shares outstanding
353.02MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Nuvation Bio Inc. filings on SEC EDGAR ↗

4:18 PM ET 8-K
Financial Results

Nuvation Bio Financial Results

Nuvation Bio reported third quarter 2026 financial results, highlighted by $45.0 million in total revenue and $27.5 million in net product revenue for its ROS1 inhibitor IBTROZI. The company ended the quarter with $663.4 million in cash and marketable securities while achieving market leadership in new patient starts for ROS1+ NSCLC.

“Just over one year after launch, IBTROZI was established as the market leader in advanced ROS1+ NSCLC, for both new patient starts and active patients across all lines of therapy combined, based on IQVIA claims data.”

David Hung, M.D., Founder, President, and Chief Executive Officer

“Our rapid rise to market leadership reflects growing provider confidence in IBTROZI’s durability of more than four years in TKI-naïve patients and a generally favorable safety profile that helps patients stay on therapy.”

David Hung, M.D., Founder, President, and Chief Executive Officer
4:10 PM ET 10-Q
Financial Results ▶ Call

Nuvation Bio Q3 2026 Results: Net Loss of $41.9M, Loss Narrows

Nuvation Bio Inc. reported financial results for the third quarter of 2026, highlighting continued progress in its clinical oncology programs. The company maintained a robust cash position to support operations through 2028, while reporting a net loss driven by ongoing research and development expenses.

Key figure
Net loss $41.9M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.